Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients

C. Chung (Taipei, Taiwan)

Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Session: Mesothelioma and malignant pleural disease
Session type: Poster Discussion
Number: 1596
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Chung (Taipei, Taiwan). Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients. 1596

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Survival of lung adenocarcinoma patients with malignant pleural effusion
Source: Eur Respir J 2013; 41: 1409-1418
Year: 2013



Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011



Malignant pericardial effusion in lung cancer patients
Source: Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions
Year: 2006

Evaluation of concomitant pleural effusions in patients with lung cancers
Source: Eur Respir J 2007; 30: Suppl. 51, 668s
Year: 2007

Management of malignant pleural effusion in recurrent SCLC by intrapleural gene therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 61s
Year: 2003

An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006


Bevacizumab-targeted therapy for malignant pleural mesothelioma
Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs
Year: 2017


Hypotonic carboplatin pleurodesis for malignant pleural effusion of non-small cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 273s
Year: 2002

Pleural effusion in lung cancer and targeted therapy
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013

Oncodrivers in malignant pleural effusions associated with non-small cell lung cancer
Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema
Year: 2020


Chemotherapy for treatment of malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 526s
Year: 2004

Pleural effusions in lung cancer
Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions
Year: 2012

Thoracoscopy in malignant pleural effusions secondary to breast cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 611s
Year: 2006

Systemic treatment of malignant pleural effusion
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005


The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 93s
Year: 2006

Pleural effusion in cases of breast carcinoma
Source: Eur Respir J 2003; 22: Suppl. 45, 62s
Year: 2003

Videothoracoscopy in the treatment of malignant pleural effusions
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009

Talc chemotherapeutic pleurodesis to palliate malignant pleural effusions secondary to breast cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 509s
Year: 2003

Surgery for lung cancer with pleural effusion
Source: Eur Respir J 2002; 20: Suppl. 38, 180s
Year: 2002

Multimodality therapy for malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 526s
Year: 2004